Use of pragmatic and explanatory trial designs in acute care research: lessons from COVID-19

Baden, 2021, Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine, N Engl J Med, 384, 403, 10.1056/NEJMoa2035389 Polack, 2020, Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine, N Engl J Med, 383, 2603, 10.1056/NEJMoa2034577 Dagan, 2021, BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting, N Engl J Med, 384, 1412, 10.1056/NEJMoa2101765 Weinreich, 2021, REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19, N Engl J Med, 384, 238, 10.1056/NEJMoa2035002 Chen, 2021, SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19, N Engl J Med, 384, 229, 10.1056/NEJMoa2029849 Cohen, 2021, Monoclonal antibodies to disrupt progression of early Covid-19 infection, N Engl J Med, 384, 289, 10.1056/NEJMe2034495 Beigel, 2020, Remdesivir for the treatment of Covid-19 — final report, N Engl J Med, 383, 1813, 10.1056/NEJMoa2007764 Horby, 2021, Dexamethasone in hospitalized patients with Covid-19, N Engl J Med, 384, 693, 10.1056/NEJMoa2021436 2021, Interleukin-6 receptor antagonists in critically ill patients with Covid-19, N Engl J Med, 384, 1491, 10.1056/NEJMoa2100433 Abani, 2021, Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial, Lancet, 397, 1637, 10.1016/S0140-6736(21)00676-0 Mu, 2021, HIV mRNA vaccines-progress and future paths, Vaccines (Basel), 9, 134, 10.3390/vaccines9020134 Kose, 2019, A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection, Sci Immunol, 4, 10.1126/sciimmunol.aaw6647 Miao, 2021, mRNA vaccine for cancer immunotherapy, Mol Cancer, 20, 41, 10.1186/s12943-021-01335-5 Angus, 2021, Emerging lessons from COVID-19 for the US clinical research enterprise, JAMA, 325, 1159, 10.1001/jama.2021.3284 Harhay, 2020, Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop, Intensive Care Med, 46, 930, 10.1007/s00134-020-05934-6 Beskow, 2020, Consent for acute care research and the regulatory “gray zone”, Am J Bioeth, 20, 26, 10.1080/15265161.2020.1745950 Iwashyna, 2015, Implications of heterogeneity of treatment effect for reporting and analysis of randomized trials in critical care, Am J Respir Crit Care Med, 192, 1045, 10.1164/rccm.201411-2125CP Reddy, 2020, Subphenotypes in critical care: translation into clinical practice, Lancet Respir Med, 8, 631, 10.1016/S2213-2600(20)30124-7 Patel, 2021, A randomized trial of otilimab in severe COVID-19 pneumonia (OSCAR), medRxiv 2021, A Neutralizing monoclonal antibody for hospitalized patients with Covid-19, N Engl J Med, 384, 905, 10.1056/NEJMoa2033130 Fanaroff, 2019, Levels of evidence supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008–2018, JAMA, 321, 1069, 10.1001/jama.2019.1122 Sims, 2019, Above the GRADE: evaluation of guidelines in critical care medicine, Crit Care Med, 47, 109, 10.1097/CCM.0000000000003467 Zhang, 2018, Scientific evidence underlying the recommendations of critical care clinical practice guidelines: a lack of high level evidence, Intensive Care Med, 44, 1189, 10.1007/s00134-018-5142-8 Simon, 2020, Evidence from pragmatic trials during routine care — slouching toward a learning health system, N Engl J Med, 382, 1488, 10.1056/NEJMp1915448 Faden, 2013, An ethics framework for a learning health care system: a departure from traditional research ethics and clinical ethics, Hastings Cent Rep, 43, S16, 10.1002/hast.134 2021, Therapeutic anticoagulation with heparin in critically ill patients with Covid-19, N Engl J Med, 385, 777, 10.1056/NEJMoa2103417 Koyfman, 2016, Informed consent conversations and documents: A quantitative comparison, Cancer, 122, 464, 10.1002/cncr.29759 Schwartz, 1967, Explanatory and pragmatic attitudes in therapeutical trials, J Chronic Dis, 20, 637, 10.1016/0021-9681(67)90041-0 Loudon, 2015, The PRECIS-2 tool: designing trials that are fit for purpose, BMJ, 350, 10.1136/bmj.h2147 2020, Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial, Lancet, 396, 1345, 10.1016/S0140-6736(20)32013-4 Abaleke, 2021, Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial, Lancet, 397, 605, 10.1016/S0140-6736(21)00149-5 Semler, 2018, Balanced crystalloids versus saline in critically ill adults, N Engl J Med, 378, 829, 10.1056/NEJMoa1711584 Self, 2018, Balanced crystalloids versus saline in noncritically ill adults, N Engl J Med, 378, 819, 10.1056/NEJMoa1711586 Shah, 2018, High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial, Lancet, 392, 919, 10.1016/S0140-6736(18)31923-8 Adler-Milstein, 2017, Moving past the EHR interoperability blame game, NEJM Catalyst Young, 2020, Effect of stress ulcer prophylaxis with proton pump inhibitors vs histamine-2 receptor blockers on in-hospital mortality among ICU patients receiving invasive mechanical ventilation: the PEPTIC randomized clinical trial, JAMA, 323, 616, 10.1001/jama.2019.22190 Fröbert, 2013, Thrombus aspiration during ST-segment elevation myocardial infarction, N Engl J Med, 369, 1587, 10.1056/NEJMoa1308789 Marquis-Gravel, 2020, Rationale and design of the aspirin dosing—a patient-centric trial assessing benefits and long-term effectiveness (ADAPTABLE) trial, JAMA Cardiol, 5, 598, 10.1001/jamacardio.2020.0116 Matthay, 2021, IL-6 receptor antagonist therapy for patients hospitalized for COVID-19: who, when, and how?, JAMA, 326, 483, 10.1001/jama.2021.11121 2000, Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome, N Engl J Med, 342, 1301, 10.1056/NEJM200005043421801 Ranieri, 2012, Drotrecogin alfa (activated) in adults with septic shock, N Engl J Med, 366, 2055, 10.1056/NEJMoa1202290 2006, Comparison of two fluid-management strategies in acute lung injury, N Engl J Med, 354, 2564, 10.1056/NEJMoa062200 Roberts, 2004, Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial, Lancet, 364, 1321, 10.1016/S0140-6736(04)17188-2 Janz, 2016, Randomized trial of video laryngoscopy for endotracheal intubation of critically ill adults, Crit Care Med, 44, 1980, 10.1097/CCM.0000000000001841 Semler, 2017, A multicenter, randomized trial of ramped position vs sniffing position during endotracheal intubation of critically ill adults, Chest, 152, 712, 10.1016/j.chest.2017.03.061 Casey, 2019, Bag-mask ventilation during tracheal intubation of critically ill adults, N Engl J Med, 380, 811, 10.1056/NEJMoa1812405 Driver, 2018, Effect of use of a bougie vs endotracheal tube and stylet on first-attempt intubation success among patients with difficult airways undergoing emergency intubation: a randomized clinical trial, JAMA, 319, 2179, 10.1001/jama.2018.6496 Caputo, 2017, Emergency department use of apneic oxygenation versus usual care during rapid sequence intubation: a randomized controlled trial (the ENDAO trial), Acad Emerg Med, 24, 1387, 10.1111/acem.13274 Semler, 2017, Balanced crystalloids versus saline in the intensive care unit. The SALT randomized trial, Am J Respir Crit Care Med, 195, 1362, 10.1164/rccm.201607-1345OC Wilson, 2021, Electronic health record alerts for acute kidney injury: multicenter, randomized clinical trial, BMJ, 372 Emanuel, 2000, What makes clinical research ethical?, JAMA, 283, 2701, 10.1001/jama.283.20.2701 1996, The Nuremberg Code, JAMA, 276 1997, Recommendations guiding physicians in biomedical research involving human subjects, JAMA, 277, 925, 10.1001/jama.1997.03540350075038 Hillier, 2021, A pragmatic, randomized clinical trial of gestational diabetes screening, N Engl J Med, 384, 895, 10.1056/NEJMoa2026028 Feldman, 2018, A systematic review of the Food And Drug Administration's ‘exception from informed consent’ pathway, Health Aff (Millwood), 37, 1605, 10.1377/hlthaff.2018.0501 Klein, 2018, A 20-year review: the use of exception from informed consent and waiver of informed consent in emergency research, Acad Emerg Med, 25, 1169, 10.1111/acem.13438 Feldman, 2019, Public approval of exception from informed consent in emergency clinical trials: a systematic review of community consultation surveys, JAMA Netw Open, 2, 10.1001/jamanetworkopen.2019.7591 Faden, 2014, Informed consent, comparative effectiveness, and learning health care, N Engl J Med, 370, 766, 10.1056/NEJMhle1313674 Kass, 2012, Addressing low-risk comparative effectiveness research in proposed changes to US federal regulations governing research, JAMA, 307, 1589, 10.1001/jama.2012.491 Faden, 2014, Informed consent for comparative effectiveness trials, N Engl J Med, 370, 1959, 10.1056/NEJMhle1313674 Morain, 2017, Stakeholder perspectives regarding alternate approaches to informed consent for comparative effectiveness research, Learn Health Syst, 2 Guyatt, 2008, GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, BMJ, 336, 924, 10.1136/bmj.39489.470347.AD Platt, 2014, Ethics, regulation, and comparative effectiveness research: time for a change, JAMA, 311, 1497, 10.1001/jama.2014.2144 Lantos, 2015, Considerations in the evaluation and determination of minimal risk in pragmatic clinical trials, Clin Trials, 12, 485, 10.1177/1740774515597687 Goldstein, 2018, Ethical issues in pragmatic randomized controlled trials: a review of the recent literature identifies gaps in ethical argumentation, BMC Med Ethics, 19, 14, 10.1186/s12910-018-0253-x Thompson, 2007, Usual care as the control group in clinical trials of nonpharmacologic interventions, Proc Am Thorac Soc, 4, 577, 10.1513/pats.200706-072JK Morain Self, 2020, Effect of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19: a randomized clinical trial, JAMA, 324, 2165, 10.1001/jama.2020.22240 Casey, 2020, Rationale and design of ORCHID: a randomized placebo-controlled clinical trial of hydroxychloroquine for adults hospitalized with COVID-19, Ann Am Thorac Soc, 17, 1144, 10.1513/AnnalsATS.202005-478SD Bull-Otterson, 2020, Hydroxychloroquine and chloroquine prescribing patterns by provider specialty following initial reports of potential benefit for COVID-19 treatment — United States, January–June 2020, MMWR Morb Mortal Wkly Rep, 69, 1210, 10.15585/mmwr.mm6935a4 Horby, 2020, Effect of hydroxychloroquine in hospitalized patients with Covid-19, N Engl J Med, 383, 2030, 10.1056/NEJMoa2022926 Cavalcanti, 2020, Hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19, N Engl J Med, 383, 2041, 10.1056/NEJMoa2019014 2021, Repurposed antiviral drugs for Covid-19 — interim WHO Solidarity trial results, N Engl J Med, 384, 497, 10.1056/NEJMoa2023184 Ulrich, 2020, Treating COVID-19 With Hydroxychloroquine (TEACH): a multicenter, double-blind randomized controlled trial in hospitalized patients, Open Forum Infect Dis, 7, 10.1093/ofid/ofaa446 Dequin, 2020, Effect of hydrocortisone on 21-day mortality or respiratory support among critically ill patients with COVID-19: a randomized clinical trial, JAMA, 324, 1298, 10.1001/jama.2020.16761 Tomazini, 2020, Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial, JAMA, 324, 1307, 10.1001/jama.2020.17021 Sterne, 2020, Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis, JAMA, 324, 1330, 10.1001/jama.2020.17023 2020, Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis, JAMA, 324, 1330, 10.1001/jama.2020.17023 Angus, 2020, Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial, JAMA, 324, 1317, 10.1001/jama.2020.17022 Gupta, 2020, Factors associated with death in critically ill patients with coronavirus disease 2019 in the US, JAMA Intern Med, 180, 1436, 10.1001/jamainternmed.2020.3596 Abani, 2021, Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial, Lancet, 397, 2049, 10.1016/S0140-6736(21)00897-7 Emanuel, 2021, Assessment of length and readability of informed consent documents for COVID-19 vaccine trials, JAMA Netw Open, 4, 10.1001/jamanetworkopen.2021.10843 Flory, 2004, Interventions to improve research participants' understanding in informed consent for research: a systematic review, JAMA, 292, 1593, 10.1001/jama.292.13.1593 Kimmelman, 2007, The therapeutic misconception at 25: treatment, research, and confusion, Hastings Cent Rep, 37, 36, 10.1353/hcr.2007.0092 Davidson, 2020, Validity of acute cardiovascular outcome diagnoses recorded in European electronic health records: a systematic review, Clin Epidemiol, 12, 1095, 10.2147/CLEP.S265619 McKown, 2019, External validity of electronic sniffers for automated recognition of acute respiratory distress syndrome, J Intensive Care Med, 34, 946, 10.1177/0885066617720159 Day, 2000, Statistics notes: blinding in clinical trials and other studies, BMJ, 321, 504, 10.1136/bmj.321.7259.504 Rice, 2020, Proton pump inhibitors vs histamine-2 receptor blockers for stress ulcer prophylaxis in critically ill patients: issues of interpretability in pragmatic trials, JAMA, 323, 611, 10.1001/jama.2019.22436 2022, Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial, Lancet, 399, 665, 10.1016/S0140-6736(22)00163-5 Platt, 2021, Is learning worth the trouble? — Improving health care system participation in embedded research, N Engl J Med, 385, 5, 10.1056/NEJMp2101700